EXL posts 16% growth as AI demand powers BPM
NEW YORK, UNITED STATES — ExlService Holdings posted $594.8 million in second quarter 2026 revenue — a 15.6% year-on-year increase — led by 22% growth in its healthcare and life sciences segment to $158 million, as enterprise demand for AI-augmented business process management (BPM) drove double-digit expansion across every service vertical.
EXL’s Q2 2026 results reflect accelerating momentum through the first half of the year, with healthcare and life sciences becoming the company’s fastest-growing segment even as insurance — EXL’s largest vertical at $197.8 million — posted 14.9% growth simultaneously.
Healthcare and life sciences grows 22% to $158M, leading EXL’s four-segment Q2 expansion
EXL’s Q2 2026 results show coordinated double-digit growth across all four operating segments: healthcare and life sciences at $158.0 million (+22.0%); insurance at $197.8 million (+14.9%); banking, capital markets, and diversified industries at $133.9 million (+10.6%); and international growth markets at $105.1 million (+14.6%).
The breadth of growth — with no segment below 10% — reflects AI-augmented demand driving expansion beyond EXL’s core insurance vertical and into healthcare and international delivery simultaneously.
EXL‘s June 2026 acquisition of iMerit, an enterprise AI and machine learning data services provider, supplements organic BPM growth with capability in the foundation model infrastructure that enterprise clients are deploying to build AI-augmented workflows.
EXL’s healthcare segment crossing $158 million at a 22% growth rate positions it as one of the sector’s fastest-growing healthcare outsourcing businesses — signaling that healthcare payers, providers, and life sciences companies are accelerating BPM outsourcing commitments as AI-augmented processes create measurable cost and quality advantages.
“We entered 2026 with strong momentum that accelerated through the first half, delivering second quarter revenue growth of 16% year-on-year and adjusted diluted EPS of 22%,” said Rohit Kapoor, Chairman and Chief Executive Officer, ExlService Holdings.
EXL raises full-year 2026 organic growth guidance to 13–14%
EXL revised its full-year 2026 organic constant-currency revenue growth guidance upward to 13% to 14%, with total 2026 revenue now projected at $2.390 billion to $2.415 billion — representing 14% to 16% year-on-year growth including $28 million to $32 million from the iMerit acquisition.
Adjusted diluted earnings per share for full-year 2026 are guided at $2.25 to $2.29, representing a 16% to 18% year-on-year increase that reflects operating margin improvement alongside accelerating top-line growth.
EXL’s raised guidance signals that pipeline visibility extends beyond Q2 — with the company citing “healthy pipeline” as the basis for increasing the full-year organic growth range at the mid-year reporting point.
The combination of a 22%-growth healthcare segment, raised full-year organic guidance to 13–14%, and iMerit’s AI capability acquisition positions EXL as a compound-growth story in healthcare BPM — one where organic demand acceleration and inorganic capability expansion are advancing simultaneously.
“Our strong second quarter performance, sustained growth momentum and healthy pipeline give us the confidence to increase our organic full-year revenue growth guidance to 13% to 14%,” said Maurizio Nicolelli, Chief Financial Officer, ExlService Holdings.
For healthcare payers, providers, and life sciences companies sourcing BPM services, EXL’s Q2 trajectory — 22% segment growth, raised guidance, and an AI acquisition — signals that leading BPM operators are deepening healthcare delivery capability precisely as enterprise AI adoption accelerates demand for specialized outsourced process management.
The 22% growth rate, running well ahead of EXL’s 16% consolidated growth, indicates healthcare organizations are expanding existing EXL relationships rather than simply renewing at prior volumes.
Related news
- Cognizant Q2 revenue rises 4.5% to $5.5 billion · 04 Aug
- Infosys holds steady as digital services lift margins · 24 Jul
- TP wants all 500,000 staff AI-enabled by 2027 · 23 Jul
Disclosure: Outsource Accelerator uses AI tools in the backend of its editorial workflow. Every article is reviewed and verified by a human editor before publication.
Stay ahead in healthcare outsourcing. Join thousands of healthcare and business leaders who rely on Outsource Accelerator for the news, trends, and expert insights shaping medical BPO and the future of care delivery. Subscribe to our free newsletter and never miss an update.
